Bay Street News, January 4th, 2019

CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics Novosanis’ […]

Company to Focus its Resources on Advancing XMT-1536, its First-in-Class ADC Candidate Targeting NaPi2b, Showing Encouraging Early Signs of Efficacy […]

-PDUFA action date set for June 30, 2019- DUBLIN, Ireland, Jan. 04, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: […]

SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”) announced today that Dr. Henry Ji, […]

ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Jan. 04, 2019 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) […]

CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target […]

Charlotte, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated design and manufacturer […]

HAMILTON, BERMUDA, January 4, 2019 – DHT Holdings, Inc. (NYSE: DHT) (“DHT” or the “Company”) today announces that its Co-CEOs […]

VAN BUREN TOWNSHIP, Mich., Jan. 04, 2019 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC), a leading global supplier of vehicle […]

VIRGINIA BEACH, Va., Jan. 04, 2019 (GLOBE NEWSWIRE) — Armada Hoffler Properties, Inc. (NYSE: AHH) announced today that it has […]